ASS1 and glioblastoma: Furthermore, these findings are consistent with the recent publication showing that the arginine pathway is significantly upregulated in the GBM neurosphere and could be selectively targeted using the ASS1 inhibitor α-methyl-DL-aspartic acid (MDLA) [40].